Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
148 studies found for:    curcumin
Show Display Options
Rank Status Study
1 Completed Effects of Curcumin on Vascular Reactivity
Sponsor/Collaborators: University Hospital, Clermont-Ferrand;   Institut National de la Recherche Agronomique;   Association Régionale de Cardiologie d’Auvergne;   ARDEC Association de Recherche de Développement et d’Enseignement de la Cardiologie
Study Design: Allocation: Randomized;   Intervention Model: Crossover Assignment;   Masking: Double Blind (Participant, Investigator);   Primary Purpose: Treatment
Age: 50 Years to 70 Years   (Adult, Senior)
Other IDs: CHU-0113
Study Start: February 2012
First Received: February 16, 2012
Last Updated: July 4, 2014
2 Unknown  Curcumin Therapy in Patients With Impaired Glucose Tolerance and Insulin Resistance
Sponsor/Collaborators: Srinakharinwirot University;   Ministry of Health, Thailand
Study Design: Allocation: Randomized;   Intervention Model: Parallel Assignment;   Masking: Single Blind (Investigator);   Primary Purpose: Prevention
Age: 35 Years and older   (Adult, Senior)
Other IDs: SWUEC9/2552
Study Start: August 2009
First Received: January 19, 2010
Last Updated: January 19, 2010
3 Completed Effect of Supplemental Oral Curcumin in Patients With Atopic Asthma
Sponsor: University of South Florida
Study Design: Allocation: Randomized;   Intervention Model: Parallel Assignment;   Masking: Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor);   Primary Purpose: Treatment
Age: 18 Years to 60 Years   (Adult)
Other IDs: curcumin
Study Start: March 2009
First Received: August 9, 2010
Last Updated: August 10, 2010
4 Active, not recruiting 18-Month Study of Curcumin
Sponsor: University of California, Los Angeles
Study Design: Allocation: Randomized;   Intervention Model: Parallel Assignment;   Masking: Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor);   Primary Purpose: Supportive Care
Age: 50 Years to 90 Years   (Adult, Senior)
Other IDs: 11-001740,   IND 112714
Study Start: March 2012
First Received: June 22, 2011
Last Updated: December 2, 2015
5 Not yet recruiting Curcumin and Function in Older Adults
Sponsor/Collaborators: University of Florida;   National Institute on Aging (NIA)
Study Design: Allocation: Randomized;   Intervention Model: Parallel Assignment;   Masking: Participant, Investigator;   Primary Purpose: Prevention
Age: 70 Years to 99 Years   (Senior)
Other IDs: IRB201600334,   P30AG028740
Study Start: May 1, 2017
First Received: March 15, 2017
Last Updated: April 10, 2017
6 Completed
Has Results
Oral Curcumin for Radiation Dermatitis
Sponsor/Collaborators: University of Rochester;   National Cancer Institute (NCI)
Study Design: Allocation: Randomized;   Intervention Model: Parallel Assignment;   Masking: Double Blind (Participant, Care Provider, Investigator);   Primary Purpose: Prevention
Age: 21 Years to 120 Years   (Adult, Senior)
Other IDs: URCC 10054,   URCC 09005,   U10CA037420
Study Start: February 2011
First Received: November 22, 2010
Last Updated: February 8, 2016
7 Recruiting Topical Curcumin for Precancer Cervical Lesions
Sponsor: Emory University
Study Design: Allocation: Randomized;   Intervention Model: Parallel Assignment;   Masking: Single Blind (Outcomes Assessor);   Primary Purpose: Treatment
Age: 21 Years and older   (Adult, Senior)
Other IDs: IRB00079183
Study Start: October 2016
First Received: October 24, 2016
Last Updated: October 24, 2016
8 Completed Curcumin Biomarkers
Sponsor: University of North Carolina, Chapel Hill
Study Design: Intervention Model: Single Group Assignment;   Masking: Open Label
Age: 40 Years to 80 Years   (Adult, Senior)
Other IDs: 10-1524
Study Start: November 2010
First Received: April 6, 2011
Last Updated: February 6, 2013
9 Active, not recruiting Topical Application of Curcumin Orabase in Oral Submucous Fibrosis (OSMF)
Sponsor: SVS Institute of Dental Sciences
Study Design: Intervention Model: Single Group Assignment;   Masking: Open Label;   Primary Purpose: Treatment
Age: 22 Years to 45 Years   (Adult)
Other IDs: SVSIDS/OMR/EX1/2013
Study Start: December 2013
First Received: December 29, 2015
Last Updated: January 4, 2016
10 Completed Trial on Safety and Pharmacokinetics of Intravaginal Curcumin
Sponsor: Emory University
Study Design: Intervention Model: Single Group Assignment;   Masking: Open Label;   Primary Purpose: Treatment
Age: 18 Years to 45 Years   (Adult)
Other IDs: IRB00020139
Study Start: January 2010
First Received: December 17, 2009
Last Updated: November 27, 2013
11 Recruiting A Open-label Prospective Cohort Trial of Curcumin Plus Tyrosine Kinase Inhibitors (TKI) for EGFR -Mutant Advanced NSCLC
Sponsor/Collaborators: Lady Davis Institute;   Jewish General Hospital
Study Design: Intervention Model: Single Group Assignment;   Masking: Open Label
Age: 18 Years and older   (Adult, Senior)
Other IDs: JGH-14-149
Study Start: August 2015
First Received: December 1, 2014
Last Updated: September 1, 2015
12 Active, not recruiting Study Investigating the Ability of Plant Exosomes to Deliver Curcumin to Normal and Colon Cancer Tissue
Sponsor/Collaborators: James Graham Brown Cancer Center;   University of Louisville
Study Design: Allocation: Randomized;   Intervention Model: Factorial Assignment;   Masking: No masking;   Primary Purpose: Treatment
Age: 20 Years and older   (Adult, Senior)
Other IDs: BCC-GI-10 Curcumin
Study Start: January 2011
First Received: February 3, 2011
Last Updated: March 1, 2017
13 Completed The Effects of Oral Curcumin on Heme Oxygenase-1 (HO-1) in Healthy Male Subjects
Sponsor/Collaborators: Daniel Doberer;   Medical University of Vienna
Study Design: Allocation: Non-Randomized;   Intervention Model: Single Group Assignment;   Masking: Open Label;   Primary Purpose: Treatment
Age: 18 Years to 45 Years   (Adult)
Other IDs: EudraCT - 2008-004900-30
Study Start: January 2009
First Received: May 6, 2009
Last Updated: January 16, 2013
14 Unknown  Curcumin for Type 2 Diabetic Patients
Sponsor/Collaborators: Srinakharinwirot University;   Ministry of Health, Thailand
Study Design: Allocation: Randomized;   Intervention Model: Parallel Assignment;   Masking: Single Blind (Investigator);   Primary Purpose: Treatment
Age: 35 Years and older   (Adult, Senior)
Other IDs: SWUEC30/2550
Study Start: July 2009
First Received: January 19, 2010
Last Updated: January 19, 2010
15 Active, not recruiting Use of Curcumin for Treatment of Intestinal Adenomas in Familial Adenomatous Polyposis (FAP)
Sponsor: University of Puerto Rico
Study Design: Allocation: Randomized;   Intervention Model: Parallel Assignment;   Masking: Double Blind (Participant, Investigator);   Primary Purpose: Treatment
Age: 21 Years to 85 Years   (Adult, Senior)
Other IDs: Protocol A2210108-UPR
Study Start: November 2007
First Received: June 24, 2009
Last Updated: December 12, 2016
16 Recruiting A Pilot Trial of Curcumin Effects on Cognition in Schizophrenia
Sponsor: Yale University
Study Design: Allocation: Randomized;   Intervention Model: Parallel Assignment;   Masking: Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor);   Primary Purpose: Treatment
Age: 18 Years to 65 Years   (Adult)
Other IDs: 1412015121
Study Start: February 2016
First Received: May 5, 2015
Last Updated: June 13, 2016
17 Recruiting Curcumin Associated With Thiopurin in the Prevention of Post-op Recurrence in Crohn Disease
Sponsor/Collaborators: University Hospital, Clermont-Ferrand;   3i nature;   Naturopôle Nutrition santé
Study Design: Allocation: Randomized;   Intervention Model: Parallel Assignment;   Masking: Double Blind (Participant, Investigator);   Primary Purpose: Treatment
Age: 18 Years and older   (Adult, Senior)
Other IDs: CHU-0207,   2014-000261-51
Study Start: December 2014
First Received: September 19, 2014
Last Updated: July 25, 2016
18 Unknown  Curcumin as a Novel Treatment to Improve Cognitive Dysfunction in Schizophrenia
Sponsor/Collaborators: VA Greater Los Angeles Healthcare System;   Stanley Medical Research Institute;   Theravalues, Inc.;   University of California, Los Angeles
Study Design: Allocation: Randomized;   Intervention Model: Parallel Assignment;   Masking: Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor);   Primary Purpose: Treatment
Age: 18 Years to 65 Years   (Adult)
Other IDs: 2013-121701
Study Start: July 2014
First Received: April 1, 2014
Last Updated: July 19, 2014
19 Not yet recruiting Curcumin Supplementation for Gynecological Diseases
Sponsor: Meir Medical Center
Study Design: Allocation: Randomized;   Intervention Model: Parallel Assignment;   Masking: Open Label;   Primary Purpose: Treatment
Age: 18 Years to 52 Years   (Adult)
Other IDs: 0210-16-MMC
Study Start: January 2017
First Received: December 11, 2016
Last Updated: January 11, 2017
20 Recruiting Curcumin Addition to Antipsychotic Treatment in Chronic Schizophrenia Patients
Sponsor/Collaborators: Beersheva Mental Health Center;   Tirat Carmel Mental Health Center
Study Design: Allocation: Randomized;   Intervention Model: Single Group Assignment;   Masking: Double Blind (Participant, Care Provider, Investigator);   Primary Purpose: Treatment
Age: 18 Years to 60 Years   (Adult)
Other IDs: VLJB-14
Study Start: January 2015
First Received: November 18, 2014
Last Updated: January 12, 2016

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.